Design and evaluation of self-nanoemulsifying pellets of repaglinide

AAPS PharmSciTech

Volumn 14, Issue 3, 2013, Pages 994-1003

  Desai, N S ^a   Nagarsenker, M S ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

anti hyperglycemic activity; extrusion spheronization; repaglinide; self nanoemulsifying pellets

Indexed keywords

GLUCOSE; LACTOSE; MICROCRYSTALLINE CELLULOSE; REPAGLINIDE; STREPTOZOCIN; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PELLET; DRUG RELEASE; DRUG SOLUBILITY; EVALUATION; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; NANOEMULSION; NONHUMAN; PELLET EXTRUSION; PH; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SELF NANOEMUSIFYING PELLET; SPHERONIZATION; X RAY POWDER DIFFRACTION;

ANIMALS; CARBAMATES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DESIGN; EMULSIONS; HYDROGEN-ION CONCENTRATION; HYPOGLYCEMIC AGENTS; MICROSCOPY, ELECTRON, SCANNING; NANOSTRUCTURES; PIPERIDINES; POWDER DIFFRACTION; RATS; SOLUBILITY; SURFACE-ACTIVE AGENTS;

EID: 84890177977     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-013-9990-9     Document Type: Article

References (32)

1. Humberstone AJ, Charman WN. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev. 1997;25:103-28.
2. Culy C, Jarvis B. Repaglinide, a review of its therapeutic use in type 2 diabetes mellitus. Drugs. 2001;61:1625-60.
3. Malaisse W. Repaglinide, a new oral antidiabetic agent: a review of recent preclinical studies. Eur J Clin Invest. 1999;29:21-9.
4. Mandic Z, Gabelica V. Ionization, lipophilicity and solubility properties of repaglinide. J Pharm Biomed Anal. 2006;41(3):866-71.
5. Marbury TC, Ruckle JL, Hatorp V, Andersen MP, Nielsen KK, Huang WC, et al. Pharmacokinetics of repaglinide in subjects with renal impairment. Clin Pharmacol Ther. 2000;67:7-15.
6. Davis SN, Granner DK. Insulin, oral hypoglycemic agents and the pharmacology of the endocrine pancreas. In: Hardman JG, Limbrid LE, editors. Goodman and Gilman's the pharmacological basis of therapeutics. USA: McGraw-Hill; 2001. p. 1704-5.
7. Sinswat P, Matteucci ME, Johnston KP, Williams III RO. Dissolution rates and supersaturation behavior of amorphous repaglinide particles produced by controlled precipitation. J Biomed Nanotechnol. 2007;3:18-27.
8. Desai NS, Bramhane DM, Nagarsenker MS. Repaglinide-cyclodextrin complexes: preparation, characterization and in vivo evaluation of antihyperglycemic activity. J Incl Phenom Macrocycl Chem. 2011;70(1-2):217-25.
9. Zawar LR, Bari SB. Preparation, characterization and in vivo evaluation of antihyperglycemic activity of microwave generated repaglinide solid dispersion. Chem Pharm Bull. 2012;60(4):482-7.
10. Kavitha R, Sathali AAH. Enhancement of solubility of repaglinide by solid dispersion technique. Int J Chem Sci. 2012;10(1):377-90.
11. Patel M, Pandya N, Bhaskar VH. Preparation, characterization and in vitro evaluation of repaglinide binary solid dispersions with hydrophilic polymers. Int J Drug Dev & Res. 2011;3(2):107-17.
12. Seedher N, Kanojia M. Micellar solubilization of some poorly soluble antidiabetic drugs: a technical note. AAPS PharmSciTech. 2008;9(2):431-6.
13. Purvis T, Mattucci ME, Todd MC, Johnston KP, Williams III RO. Rapidly dissolving repaglinide powders produced by the ultra-rapid freezing process. AAPS PharmSciTech. 2007;8(3):E52-60.
14. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58:173-82.
15. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2000;45:89-121.
16. Wei W, Yang W, Li Q. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur J Pharm Biopharm. 2006;63:288-94.
17. Date A, Desai N, Dixit R, Nagarsenker M. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine. 2010;5(10):1595-616.
18. Chang RK, Raghavan KS, Hussain MA. A study on gelatin capsule brittleness: moisture transfer between the capsule shell and its content. J Pharm Sci. 1998;87:556-8.
19. Mei X, Etzler FM, Wang Z. Use of texture analyzer to study hydrophilic solvent effects on the mechanical properties of hard gelatin capsules. Int J Pharm. 2006;324:128-35.
20. Mahmoud EA, Bendas ER, Mohamed MI. Preparation and evaluation of self-nanoemulsifying tablets of carvedilol. AAPS Pharm Sci Tech. 2009;10:183-92.
21. Dixit RP, Nagarsenker MS. Formulation and in vivo evaluation of self-nanoemulsifying granules for oral delivery of a combination of ezetimibe and simvastatin. Drug Dev Ind Pharm. 2008;34:1285-96.
22. Balakrishnan P, Lee BJ, Oh DH, Kim JO, Hong MJ, Jee JP, et al. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm. 2009;72:539-45.
23. Tuleu C, Newton JM, Rose J, Euler D, Saklatvala R, Clarke A, et al. Comparative bioavailability study in dogs of a self emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone. J Pharm Sci. 2004;93:1495-502.
24. Newton JM, Pinto MR, Podczeck F. The preparation of pellets containing a surfactant or a mixture of mono- and di-glycerides by extrusion/spheronization. Eur J Pharm Sci. 2007;30:333-42.
25. Xiongwei H, Chen L, Dingxiong C, Jing Z, Zhihong L, Wei W, et al. Sirolimus solid self-microemulsifying pellets: formulation development, characterization and bioavailability evaluation. Int J Pharm. 2012;438:123-33.
26. Abdalla A, Mäder K. Preparation and characterization of a self emulsifying pellet formulation. Eur J Pharm Biopharm. 2007;66:220-6.
27. Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm. 2007;329:166-72.
28. Pouton CW, Porter CJH. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 2008;60:625-37.
29. Porter CJH, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev. 2008;60:673-91.
30. Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm. 2000;50(1):179-88.
31. Newton M, Petersson J, Podczeck F, Clarke A, Booth S. The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture. J Pharm Sci. 2001;90:987-95.
32. Shah NH, Phuapradit W, Zhang Y, Ahmed H, Malick AW. Lipid-Based Isotropic Solutions: Design Considerations. In: Hauss DJ, editor. Oral lipid-based formulations enhancing the bioavailability of poorly water-soluble drugs. Informa Healthcare USA, Inc; 2007. p. 129-148.